Research and education

Up to one in every five adults1 has sleep-disordered breathing (SDB).

An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health.

Through its strong partnership with the global medical community, ResMed is committed to:

  • Increasing awareness of the dangers of untreated SDB
  • Supporting ongoing research into the correlation of SDB with other health risks
  • Finding effective clinical solutions to improve the health and lives of SDB patients

At ResMed, we are focused on developing our industry and patient expertise in sleep and respiratory disorders. That’s why we continue to research areas related to sleep-disordered breathing.

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives in five associated areas of clinical focus related to sleep-disordered breathing.

We believe that industry and medical science must work together to enhance medicine and patient therapy. Our acclaimed sleep program was developed in support of this philosophy.